4D Molecular Therapeutics (FDMT) Debt Metrics

Price: $3.34
Market Cap: $154.65M
Avg Volume: 834.68K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 2.876
52W Range: $2.235-28.927
Website: 4D Molecular Therapeutics

How much debt does 4D Molecular Therapeutics have?

According to 4D Molecular Therapeutics's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

4D Molecular Therapeutics's total debt stands at $24.61M. This is broken down into:

  • Long-term debt: $18.97M
  • Short-term debt: $5.64M

The company's net debt, which accounts for cash and cash equivalents, is $-124.73M. In terms of overall financial obligations, 4D Molecular Therapeutics's total liabilities amount to $49.78M.

Debt Ratios and Metrics

To better understand 4D Molecular Therapeutics's debt position, we can look at several key ratios:

  • Debt to Equity Ratio: 0.05 - this indicates the proportion of equity and debt the company uses to finance its assets.
  • Debt Ratio: 4.39% - this shows the proportion of a company's assets that are financed through debt.
  • Interest Coverage Ratio: 0.00 - this measures how easily a company can pay interest on its outstanding debt.
  • Long-term Debt to Capitalization: 3.58% - this shows the proportion of long-term debt in the company's capital structure.
  • Total Debt to Capitalization: 4.60% - this indicates the total debt in the company's capital structure.

These metrics provide insight into 4D Molecular Therapeutics's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.

Total Debt

$24.61M

Long-term Debt

$18.97M

Short-term Debt

$5.64M

Net Debt

$-124.73M

Total Liabilities

$49.78M

Interest Coverage

0.00

Debt to Equity Ratio

0.05

Debt Ratio

4.39%

4D Molecular Therapeutics Historical Debt Metrics
Total Debt
Long-term Debt
Short-term Debt
Net Debt
$80.00M$80.00M$0.00$0.00-$80.00M-$80.00M-$160.00M-$160.00M-$240.00M-$240.00M-$320.00M-$320.00MDebt Metrics20182018201920192020202020212021202220222023202320242024

4D Molecular Therapeutics Historical Debt

The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2024.

Year Total Debt Long-term Debt Short-term Debt Net Debt Total Liabilities Debt to Equity Debt Ratio Interest Coverage Long-term Debt to Capitalization Total Debt to Capitalization
2024 $24.61M $18.97M $5.64M $-124.73M $49.78M 0.05 4.39% 0.00 3.58% 4.60%
2023 $14.67M $11.52M $3.15M $-234.44M $32.06M 0.05 4.32% 0.00 0.00% 4.55%
2022 $16.12M $13.47M $5.31M $-202.52M $30.51M -0.05 6.16% 0.00 0.00% -5.40%
2021 $16.45M $15.22M $2.46M $-298.98M $560.48M -0.08 4.65% 0.00 0.00% -8.63%
2020 $- $- $- $-276.73M $31.94M 0.00 0.00% 0.00 0.00% 0.00%
2019 $- $- $- $-49.65M $131.20M 0.00 0.00% 0.00 0.00% 0.00%
2018 $- $- $- $-91.76M $124.56M 0.00 0.00% 0.00 0.00% 0.00%
2017 $- $- $- $-23.85M $46.91M 0.00 0.00% 0.00 0.00% 0.00%

Related Metrics

Explore detailed financial metrics and analysis for FDMT.